Citation Formats
Intra articular administrations of Allogenic Human Umblical Cord Mezenchimal Stem Cells for temporomandibular joint disorders: A phase 1/2 clinical study
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

C. A. Kemaloğlu, "Intra articular administrations of Allogenic Human Umblical Cord Mezenchimal Stem Cells for temporomandibular joint disorders: A phase 1/2 clinical study," ISAPS , İstanbul, Turkey, pp.1-2, 2022

Kemaloğlu, C. A. 2022. Intra articular administrations of Allogenic Human Umblical Cord Mezenchimal Stem Cells for temporomandibular joint disorders: A phase 1/2 clinical study. ISAPS , (İstanbul, Turkey), 1-2.

Kemaloğlu, C. A., (2022). Intra articular administrations of Allogenic Human Umblical Cord Mezenchimal Stem Cells for temporomandibular joint disorders: A phase 1/2 clinical study . ISAPS (pp.1-2). İstanbul, Turkey

Kemaloğlu, CEMAL. "Intra articular administrations of Allogenic Human Umblical Cord Mezenchimal Stem Cells for temporomandibular joint disorders: A phase 1/2 clinical study," ISAPS, İstanbul, Turkey, 2022

Kemaloğlu, CEMAL A. . "Intra articular administrations of Allogenic Human Umblical Cord Mezenchimal Stem Cells for temporomandibular joint disorders: A phase 1/2 clinical study." ISAPS , İstanbul, Turkey, pp.1-2, 2022

Kemaloğlu, C. A. (2022) . "Intra articular administrations of Allogenic Human Umblical Cord Mezenchimal Stem Cells for temporomandibular joint disorders: A phase 1/2 clinical study." ISAPS , İstanbul, Turkey, pp.1-2.

@conferencepaper{conferencepaper, author={CEMAL ALPER KEMALOĞLU}, title={Intra articular administrations of Allogenic Human Umblical Cord Mezenchimal Stem Cells for temporomandibular joint disorders: A phase 1/2 clinical study}, congress name={ISAPS}, city={İstanbul}, country={Turkey}, year={2022}, pages={1-2} }